171763-19-2
Chemical Structure
5’-O-TBDPS-5-methyl-2,2’-anhydrouridine
- CAS No.: 171763-19-2
- Formula:C26H30N2O5Si
- Molecular Weight:478.61
IUPAC Name: (2R,3R,3aS,9aR)-2-(((tert-butyldiphenylsilyl)oxy)methyl)-3-hydroxy-7-methyl-2,3,3a,9a-tetrahydro-6H-furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-6-one
InChIKey: SIZHJFXDXIEVDA-PIATZUFCSA-N
SMILES: O[C@@H]([C@@]1([H])[C@@](N2C(O1)=NC(C(C)=C2)=O)([H])O3)[C@H]3CO[Si](C4=CC=CC=C4)(C5=CC=CC=C5)C(C)(C)C
Biological Activity: 5’-O-TBDPS-5-methyl-2,2’-anhydrouridine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
5’-O-TBDPS-5-methyl-2,2’-anhydrouridine | 5’-O-TBDPS-5-methyl-2,2’-anhydrouridine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
